リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「SEPSIS INDUCES DEREGULATION OF IL-13 PRODUCTION AND PD-1 EXPRESSION IN LUNG GROUP 2 INNATE LYMPHOID CELLS」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

SEPSIS INDUCES DEREGULATION OF IL-13 PRODUCTION AND PD-1 EXPRESSION IN LUNG GROUP 2 INNATE LYMPHOID CELLS

Akama Yuichi 三重大学

2022.07.20

概要

Deregulation of the immune system in sepsis plays the central role in the pathogenesis of multiple organ failure including septic lung injury. Group 2 innate lymphoid cells (ILC2s) have emerged as a new player in regulating immune homeostasis in the lung; however, the role of ILC2s in lung injury in sepsis remains poorly understood. Here, we investigated temporal changes in stimulatory and inhibitory receptor expression and intracellular type 2 cytokine expression of ILC2s in the lung using a cecal ligation and puncture mouse sepsis model. We found that IL-13 production by ILC2s, which were predominately composed of the resident natural ILC2 subset rather than the migratory inflammatory ILC2 subset, was reduced in the lungs of sepsis mice on day 1 and gradually restored through day 7. Although the expression levels of ST2 and inducible T-cell costimulatory (stimulatory receptors) were high, IL-13 production by ILC2s was reduced while showing high programmed cell death 1 (PD-1) (inhibitory receptor) expression. Furthermore, using IL-33 knockout mice, we have shown that IL-33 regulates the capacity of ILC2s to produce IL-13, possibly through the modulation of ST2 and PD-1 expression and signaling in the septic lung. To the best of our knowledge, this is the first report showing differential costimulatory/inhibitory receptor expression on ILC2s in a septic lung in the context of an IL-33/IL-13 pathway-mediated type 2 immune response in the progression and resolution of inflammation. Our present findings contribute to a better understanding of the underlying immunological mechanism of ILC2s and may fill the critical knowledge gap regarding immune homeostasis in the lung that hampers the development of new therapeutic strategies for sepsis-induced acute lung injury.

参考文献

Cameron, G.J.M., Cautivo, K.M., Loering, S., Jiang, S.H., Deshpande, A.V., Foster, P.S., McKenzie, A.N.J., Molofsky, A.B., Hansbro, P.M., and Starkey, M.R. (2019). Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury. Front Immunol 10, 826.

Donovan, C., Starkey, M.R., Kim, R.Y., Rana, B.M.J., Barlow, J.L., Jones, B., Haw, T.J., Mono Nair, P., Budden, K., Cameron, G.J.M., et al. (2019). Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease. J Leukoc Biol 105, 143-150.

Gold, M.J., Antignano, F., Halim, T.Y., Hirota, J.A., Blanchet, M.R., Zaph, C., Takei, F., and McNagny, K.M. (2014). Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133, 1142-1148.

Halim, T.Y., Hwang, Y.Y., Scanlon, S.T., Zaghouani, H., Garbi, N., Fallon, P.G., and McKenzie, A.N. (2016). Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol 17, 57-64.

Halim, T.Y., MacLaren, A., Romanish, M.T., Gold, M.J., McNagny, K.M., and Takei, F. (2012). Retinoic-acid-receptor- related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 37, 463-474.

Halim, T.Y., Steer, C.A., Matha, L., Gold, M.J., Martinez-Gonzalez, I., McNagny, K.M., McKenzie, A.N., and Takei,

F. (2014). Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425-435.

Halim, T.Y.F., Rana, B.M.J., Walker, J.A., Kerscher, B., Knolle, M.D., Jolin, H.E., Serrao, E.M., Haim-Vilmovsky, L., Teichmann, S.A., Rodewald, H.R., et al. (2018). Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells. Immunity 48, 1195-1207 e1196.

Hams, E., Bermingham, R., Wurlod, F.A., Hogan, A.E., O'Shea, D., Preston, R.J., Rodewald, H.R., McKenzie, A.N., and Fallon, P.G. (2016). The helminth T2 RNase omega1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism. FASEB J 30, 824-835.

Imai, Y., Yasuda, K., Nagai, M., Kusakabe, M., Kubo, M., Nakanishi, K., and Yamanishi, K. (2019). IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils. J Invest Dermatol 139, 2185-2194 e2183.

Li, J., Razumilava, N., Gores, G.J., Walters, S., Mizuochi, T., Mourya, R., Bessho, K., Wang, Y.H., Glaser, S.S., Shivakumar, P., et al. (2014). Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest 124, 3241-3251.

Moral, J.A., Leung, J., Rojas, L.A., Ruan, J., Zhao, J., Sethna, Z., Ramnarain, A., Gasmi, B., Gururajan, M., Redmond, D., et al. (2020). ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. Nature 579, 130-135.

Newland, S.A., Mohanta, S., Clement, M., Taleb, S., Walker, J.A., Nus, M., Sage, A.P., Yin, C., Hu, D., Kitt, L.L., et al. (2017). Type-2 innate lymphoid cells control the development of atherosclerosis in mice. Nat Commun 8, 15781.

Oliphant, C.J., Hwang, Y.Y., Walker, J.A., Salimi, M., Wong, S.H., Brewer, J.M., Englezakis, A., Barlow, J.L., Hams, E., Scanlon, S.T., et al. (2014). MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41, 283-295.

Rafei-Shamsabadi, D.A., van de Poel, S., Dorn, B., Kunz, S., Martin, S.F., Klose, C.S.N., Arnold, S.J., Tanriver, Y., Ebert, K., Diefenbach, A., et al. (2018). Lack of Type 2 Innate Lymphoid Cells Promotes a Type I-Driven Enhanced Immune Response in Contact Hypersensitivity. J Invest Dermatol 138, 1962-1972.

Satoh-Takayama, N., Kato, T., Motomura, Y., Kageyama, T., Taguchi-Atarashi, N., Kinoshita-Daitoku, R., Kuroda, E., Di Santo, J.P., Mimuro, H., Moro, K., et al. (2020). Bacteria-Induced Group 2 Innate Lymphoid Cells in the Stomach Provide Immune Protection through Induction of IgA. Immunity 52, 635-649 e634.

Schwartz, C., Moran, T., Saunders, S.P., Kaszlikowska, A., Floudas, A., Bom, J., Nunez, G., Iwakura, Y., O'Neill, L., Irvine, A.D., et al. (2019). Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1beta. Allergy 74, 1920-1933.

Walker, J.A., Oliphant, C.J., Englezakis, A., Yu, Y., Clare, S., Rodewald, H.R., Belz, G., Liu, P., Fallon, P.G., and McKenzie, A.N. (2015). Bcl11b is essential for group 2 innate lymphoid cell development. J Exp Med 212, 875-882.

Xu, J., Guardado, J., Hoffman, R., Xu, H., Namas, R., Vodovotz, Y., Xu, L., Ramadan, M., Brown, J., Turnquist, H.R., et al. (2017). IL33-mediated ILC2 activation and neutrophil IL5 production in the lung response after severe trauma: A reverse translation study from a human cohort to a mouse trauma model. PLoS Med 14, e1002365.

Yasuda, K., Adachi, T., Koida, A., and Nakanishi, K. (2018). Nematode-Infected Mice Acquire Resistance to Subsequent Infection With Unrelated Nematode by Inducing Highly Responsive Group 2 Innate Lymphoid Cells in the Lung. Front Immunol 9, 2132.

参考文献をもっと見る